Evaluating a guideline-aligned prednisone threshold within the Lupus Low Disease Activity State (LLDAS): associations with damage accrual. [PDF]
Parodis I +3 more
europepmc +1 more source
Real World Use of the IL‐36 Receptor Antagonist Spesolimab: A Systematic Review and Analysis
ABSTRACT Background Spesolimab, an interleukin‐36 receptor antagonist, is approved for the treatment and prevention of generalised pustular psoriasis (GPP) flares. Its use has increasingly been reported in real‐world settings for both GPP and other inflammatory dermatoses.
Sophia A. Mense +4 more
wiley +1 more source
Clinical Phenotype, Treatment Exposure, Treat-to-Target Status, and Longitudinal Outcomes in Juvenile-Onset Systemic Lupus Erythematosus: A Single-Center Retrospective Cohort Study. [PDF]
Bozkaya Yücel B +3 more
europepmc +1 more source
TRIM Expression and Its Association With Disease Activity in Systemic Lupus Erythematosus
ABSTRACT Systemic lupus erythematosus (SLE) is a chronic autoimmune disease with diverse manifestations, including rash, arthritis, and nephritis. Although autoantibodies are a key feature of SLE, their levels often poorly reflect disease severity, suggesting the involvement of additional contributing factors.
Ling‐Ying Lu +8 more
wiley +1 more source
Correction to "Exploring the Association Between Systemic Lupus Erythematosus and High-Density Lipoproteins: A Systematic Review and Meta-Analysis". [PDF]
europepmc +1 more source
Frequency and factors associated with flare-ups in lupus patients with lupus nephritis in French Guiana. [PDF]
Makembi Bunkete A +10 more
europepmc +1 more source
ABSTRACT Mesenchymal stem cells (MSCs) have been shown to enhance tissue regeneration and wound healing. This preclinical study investigated the therapeutic potential of human bone marrow‐derived mesenchymal stem cells (hBM‐MSCs) for accelerating diabetic wound healing.
Rong‐Fu Chen +5 more
wiley +1 more source
Long‐Term Outcomes of the Anterior Ethmoidal Artery Flap for Nasal Septal Perforation Repair
While NSP closure success was 90% at 6 months postoperatively, success dropped to about 70% at final follow‐ups, with a majority of failures occurring after 1 year postoperatively. Patients most often achieved long‐term symptomatic relief and were happy they had undergone NSP repair.
John R. Craig +10 more
wiley +1 more source
Identification and Validation of Hub Genes Associated With Periodontitis and Systemic Lupus Erythematosus. [PDF]
Li Y, Xu X, Wu Z, Li F, Zhang J.
europepmc +1 more source

